glp 1 drugs alzheimer's Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science Older GLP-1 drug may help

Safran SafrInside : Saffron, derived from the stigmas of the Crocus sativus flower, is a precious spice renowned for its unique properties

Introduced in the twenty-first century, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of antidiabetic drugs noted not only for their potent glucose-lowering effects but also for their cardiovascular and renal protective benefits

Flier, for being an important part of the early discovery work, almost four decades ago.

Are they worthy of all the hype? History is littered with failed weight-loss wonder drugs

Find the best new GLP-1 drug for you.

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)